BBP

Virtus$95.30-1.65 (-1.70%)
AUM $127.5MER 0.34%NAV $98.06Holdings 198

Price Chart

Key Statistics

Previous Close

$96.95

Day Range

$95.06$97.13

52-Week Range

$76.99$109.90

Avg Volume

11.2K

Dividend Yield

—

Expense Ratio

0.34%

AUM

$127.5M

Shares Outstanding

407.5K

ETF Grades

?

Sector Breakdown

SectorWeight %
Healthcare100.00%

Country Allocation

CountryWeight %
United States95.32%
United Kingdom1.81%
China1.79%
Switzerland1.09%

Fund Information

Issuer
Virtus
Category
Healthcare
Types
Biotech
Inception Date
Dec 16, 2014
Exchange
NYSE_ARCA
Description
The Fund seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Products Index, which tracks the performance of biotechnology companies with at least one drug therapy approved by the FDA.Effective February 27, this Fund's name changed from Virtus LifeSci Biotech Products ETF to Virtus Biotech ETF.

Similar ETFs

SymbolNameAUM
XLVState Street Health Care Select Sector SPDR ETF$46.92B
VHTVanguard Health Care ETF$20.80B
VTWOVanguard Russell 2000 ETF$16.80B
RWLInvesco S&P 500 Revenue ETF$10.01B
XBIState Street SPDR S&P Biotech ETF$9.64B

The Virtus Biotech ETF (BBP) is an exchange-traded fund issued by Virtus that launched on Dec 16, 2014. It currently manages $127.5M in assets under management. The fund charges an expense ratio of 0.34%. The fund holds 198 securities in its portfolio. It falls under the Healthcare category.

Top 10 holdings represent 27.0% of the fund

RankSymbolNameWeight %SharesMarket Value
1MRNAModerna Inc5.55%35,124$7.0M
2XERSXeris Biopharma Holdings Inc3.40%258,184$4.3M
3KNSAKiniksa Pharmaceuticals International Plc2.51%33,785$3.2M
4IOVAIovance Biotherapeutics Inc2.49%429,672$3.1M
5VSTMVerastem Inc2.33%427,577$2.9M
6ADMAADMA Biologics Inc2.26%213,528$2.8M
7OMEROmeros Corp2.23%200,694$2.8M
8BGNEBeOne Medicines Ltd2.10%6,628$2.6M
9REGNRegeneron Pharmaceuticals Inc2.09%2,863$2.6M
10INSMInsmed Inc2.05%17,917$2.6M
11HALOHalozyme Therapeutics Inc1.86%25,224$2.3M
12GILDGilead Sciences Inc1.84%13,958$2.3M
13RYTMRhythm Pharmaceuticals Inc1.84%19,836$2.3M
14TGTXTG Therapeutics Inc1.82%35,401$2.3M
15ROIVRoivant Sciences Ltd1.80%58,357$2.3M
Page 1 of 4

Detailed Returns

PeriodReturnETF
1D
-1.70%
1W
-4.82%
1M
-7.41%
3M
-11.59%
6M
+8.83%
YTD
+18.61%
1Y
+21.00%
3Y
+89.90%
5Y
+92.47%

Moving Averages

20-Day MA

$102.10

Below 20-Day MA
50-Day MA

$102.99

Below 50-Day MA
200-Day MA

$93.90

Above 200-Day MA

Price with Moving Averages

Support & Resistance

52-Week High

$109.90

Current Price

$95.30

52-Week Low

$76.99

$76.99$109.90

Current Yield

—

Annual Dividend

$0.9395

Frequency

0x/year

Last Ex-Date

Dec 20, 2017

Dividend History

Ex-DateAmountPay Date
Dec 20, 2017$0.0723Dec 27, 2017
Dec 20, 2017$0.0700Dec 27, 2017
Dec 21, 2015$0.4000Dec 29, 2015
Dec 21, 2015$0.3972Dec 29, 2015

Dividend Payments Over Time

Category Comparison

MetricBBPHealthcare(212 ETFs)Biotech(41 ETFs)
Fund Info
Expense Ratio0.34%0.68%0.86%
AUM$127.5M$842.0M$1.89B
Dividend Yield—5.54%1.97%
Avg Volume11.2K257.4K1.4M
Holdings19812463
Performance
1-Month Return-9.09%-7.05%-8.04%
6-Month Return+11.67%-1.75%+5.24%
YTD Return+18.26%+2.72%+8.75%
1-Year Return—+0.26%+6.36%

Compare with Another ETF

Search for an ETF to compare with BBP:

FREE DOWNLOAD

The Beginner's Guide to ETFs

20 pages. Zero fluff. Everything you need to start investing in ETFs.

No spam. Unsubscribe anytime.